6-benzyl-3-chloro-4-methyl-pyridazine | 118270-22-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 6-benzyl-3-chloro-4-methyl-pyridazine
• 英文别名: 6-Benzyl-3-chloro-4-methylpyridazine
• CAS: 118270-22-7
• 化学式: C₁₂H₁₁ClN₂
• 分子量: 218.686
• InChiKey: CNQQNLYTDCGOGT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(2-氨基乙基)吗啉 、 6-benzyl-3-chloro-4-methyl-pyridazine 生成 6-benzyl-4-methyl-N-(2-morpholin-4-ylethyl)pyridazin-3-amine,dihydrochloride
  参考文献：
  名称：

  3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities

  摘要：

  Minaprine [3-[(beta-morpholinoethyl)amino]-4-methyl-6-phenylpyridazine dihydrochloride] is active in most animal models of depression and exhibits in vivo a dual dopaminomimetic and serotoninomimetic activity profile. In an attempt to dissociate these two effects and to characterize the responsible structural requirements, a series of 47 diversely substituted analogues of minaprine were synthesized and tested for their potential antidepressant, serotonergic, and dopaminergic activities. The structure-activity relationships show that dopaminergic and serotonergic activities can be dissociated. Serotonergic activity appears to be correlated mainly with the substituent in the 4-position of the pyridazine ring whereas the dopaminergic activity appears to be dependent on the presence, or in the formation, of a para-hydroxylated aryl ring in the 6-position of the pyridazine ring.

  DOI：

  10.1021/jm00123a004
• 作为产物：
  描述：

  6-benzyl-4-methylpyridazin-3(2H)-one 在 三氯氧磷 作用下， 生成 6-benzyl-3-chloro-4-methyl-pyridazine
  参考文献：
  名称：

  3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities

  摘要：

  Minaprine [3-[(beta-morpholinoethyl)amino]-4-methyl-6-phenylpyridazine dihydrochloride] is active in most animal models of depression and exhibits in vivo a dual dopaminomimetic and serotoninomimetic activity profile. In an attempt to dissociate these two effects and to characterize the responsible structural requirements, a series of 47 diversely substituted analogues of minaprine were synthesized and tested for their potential antidepressant, serotonergic, and dopaminergic activities. The structure-activity relationships show that dopaminergic and serotonergic activities can be dissociated. Serotonergic activity appears to be correlated mainly with the substituent in the 4-position of the pyridazine ring whereas the dopaminergic activity appears to be dependent on the presence, or in the formation, of a para-hydroxylated aryl ring in the 6-position of the pyridazine ring.

  DOI：

  10.1021/jm00123a004

文献信息

• Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened
  作者：Stefan Peukert、Feng He、Miao Dai、Rui Zhang、Yingchuan Sun、Karen Miller-Moslin、Michael McEwan、Bharat Lagu、Kate Wang、Naeem Yusuff、Aaron Bourret、Arun Ramamurthy、Wieslawa Maniara、Adam Amaral、Anthony Vattay、Anlai Wang、Ribo Guo、Jing Yuan、John Green、Juliet Williams、Silvia Buonamici、Joseph F. Kelleher、Marion Dorsch

  DOI：10.1002/cmdc.201300217

  日期：2013.8

  First disclosure: Continued optimization provided a novel type of Smoothened (Smo) antagonist based on a pyridazine core. The compound, NVP‐LEQ506, currently in phase I clinical trials, combines high intrinsic potency and good pharmacokinetic properties resulting in excellent efficacy in rodent tumor models of medulloblastoma. Activity against a Smo mutant conferring resistance observed in a previous

  首次公开：持续的优化提供了一种基于哒嗪核心的新型平滑（Smo）拮抗剂。NVP‐LEQ506化合物目前处于I期临床试验中，具有很高的内在效价和良好的药代动力学特性，在髓母细胞瘤的啮齿动物肿瘤模型中具有出色的疗效。在先前的临床试验中观察到的与竞争性化合物对抗Smo突变的耐药性的活性表明其具有更大的治疗潜力。
• WERMUTH, CAMILLE-GEORGES;SCHLEWER, GILBERT;BOURGUIGNON, JEAN-JACQUES;MAGH+, J. MED. CHEM., 32,(1989) N, C. 528-537
  作者：WERMUTH, CAMILLE-GEORGES、SCHLEWER, GILBERT、BOURGUIGNON, JEAN-JACQUES、MAGH+

  DOI：——

  日期：——